Lorenzo Ramirez-Romero

Toledo, CM 45004, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Hospital Coordination and Protocols Using Serum and Peripheral Blood Cells from Patients and Healthy Donors in a Longitudinal Study of Guillain-Barré Syndrome.

Hospital Coordination and Protocols Using Serum and Peripheral Blood Cells from Patients and Healthy Donors in a Longitudinal Study of Guillain-Barré Syndrome.

Journal: Diagnostics (Basel, Switzerland)

Published: May 13, 2025

Cellular Distribution of Pyruvate Kinase M2 After Spinal Cord Injury in Adult Rats.

Cellular Distribution of Pyruvate Kinase M2 After Spinal Cord Injury in Adult Rats.

Journal: Molecular neurobiology

Published: February 26, 2025

Emerging Roles of Bile Acids and TGR5 in the Central Nervous System: Molecular Functions and Therapeutic Implications.

Emerging Roles of Bile Acids and TGR5 in the Central Nervous System: Molecular Functions and Therapeutic Implications.

Journal: International journal of molecular sciences

Published: July 31, 2024

Improved Efficacy of Delayed Treatment with Human Bone Marrow-Derived Stromal Cells Evaluated in Rats with Spinal Cord Injury.

Improved Efficacy of Delayed Treatment with Human Bone Marrow-Derived Stromal Cells Evaluated in Rats with Spinal Cord Injury.

Journal: International journal of molecular sciences

Published: December 18, 2023

Janus Kinase Inhibitor Brepocitinib Rescues Myelin Phagocytosis Under Inflammatory Conditions: In Vitro Evidence from Microglia and Macrophage Cell Lines.

Janus Kinase Inhibitor Brepocitinib Rescues Myelin Phagocytosis Under Inflammatory Conditions: In Vitro Evidence from Microglia and Macrophage Cell Lines.

Journal: Molecular neurobiology

Published: August 12, 2023

Is TGR5 a therapeutic target for the treatment of spinal cord injury?

Is TGR5 a therapeutic target for the treatment of spinal cord injury?

Journal: Journal of neurochemistry

Published: August 31, 2022

Tauroursodeoxycholic Acid Reduces Neuroinflammation but Does Not Support Long Term Functional Recovery of Rats with Spinal Cord Injury.

Tauroursodeoxycholic Acid Reduces Neuroinflammation but Does Not Support Long Term Functional Recovery of Rats with Spinal Cord Injury.

Journal: Biomedicines

Published: April 04, 2022

Author Correction: Bile acids attenuate PKM2 pathway activation in proinflammatory microglia.

Author Correction: Bile acids attenuate PKM2 pathway activation in proinflammatory microglia.

Journal: Scientific reports

Published: February 24, 2022

Bile acids attenuate PKM2 pathway activation in proinflammatory microglia.

Bile acids attenuate PKM2 pathway activation in proinflammatory microglia.

Journal: Scientific reports

Published: October 18, 2021

Taurolithocholic acid but not tauroursodeoxycholic acid rescues phagocytosis activity of bone marrow-derived macrophages under inflammatory stress.

Taurolithocholic acid but not tauroursodeoxycholic acid rescues phagocytosis activity of bone marrow-derived macrophages under inflammatory stress.

Journal: Journal of cellular physiology

Published: June 16, 2021

Retinoic acid increases phagocytosis of myelin by macrophages.

Retinoic acid increases phagocytosis of myelin by macrophages.

Journal: Journal of cellular physiology

Published: July 31, 2020

Treatment of rats with spinal cord injury using human bone marrow-derived stromal cells prepared by negative selection.

Treatment of rats with spinal cord injury using human bone marrow-derived stromal cells prepared by negative selection.

Journal: Journal of biomedical science

Published: November 28, 2019

Showing 1-12 of 25

Last Updated: 09/26/2026